Cedazuridine + Decitabine
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Cedazuridine
cedazuridine - Decitabine
decitabine
Brands with this exact combination
| Brand | Dose | Manufacturer |
|---|---|---|
| INQOVIAUCAUS | 100 mg / 35 mg | TAIHO PHARMA CANADA, INC. |
| Inaqovi 35mg/100mg tabletsESEUGB | 35 mg / 100 mg | Otsuka Pharmaceutical Netherlands B.V. |
| Decitabine 35mg / Cedazuridine 100mg tabletsAUESGB | 35 mg / 100 mg | Otsuka Pharmaceutical Netherlands B.V. |
| CEDAZURIDINE and DECITABINEUS | 100 mg / 35 mg | Taiho Pharmaceutical Co., Ltd. |
| decitabina + cedazuridinaES | 35 mg / 100 mg | Otsuka Pharmaceutical Netherlands B.V. |
| cedazuridine + decitabineAU | — | — |
| INQOVI 35/100 decitabine 35 mg and cedazuridine 100 mg tablet blister packAU | 35 mg / 100 mg | Taiho Pharma Oceania Pty Ltd |
Same combination in other markets
These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.
- CA · INQOVI · 1 products · record
- ES · INAQOVI · 1 products · record
- GB · INAQOVI · 1 products · record
- US · INQOVI · 1 products · record
- AU · INQOVI · 1 products · record
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.